Arterial aging engages a plethora of key signalling pathways that act in concert to induce vascular smooth muscle cell (VSMC) phenotypic changes leading to vascular degeneration and extracellular matrix degradation responsible for alterations of the mechanical properties of the vascular wall. This review highlights proof-of-concept examples of components of the extracellular matrix, VSMC receptors which connect extracellular and intracellular structures, and signalling pathways regulating changes in mechanotransduction and vascular homeostasis in aging. Furthermore, it provides a new framework for understanding how VSMC stiffness and adhesion to extracellular matrix contribute to arterial stiffness and how interactions with endothelial cells, platelets, and immune cells can regulate vascular aging. The identification of the key players of VSMC changes operating in large and small-sized arteries in response to increased mechanical load may be useful to better elucidate the causes and consequences of vascular aging and associated progression of hypertension, arteriosclerosis, and atherosclerosis.
Introduction
The classical concept of arterial aging assigns an important role to arterial stiffening in the continuum between normal aging and the onset and progression of hypertension, heart failure, renal disease, and stroke. Arterial wall aging causes chronic arterial inflammation and diffuse intimal-medial thickening by vascular cell phenotypic shifts and structural modifications of the media (matrix accumulation and elastin fibre fragmentation) that drive arterial stiffness. This age-associated arterial remodelling defines arteriosclerosis and confers a major risk for atherosclerosis. Classically, atherosclerosis is viewed as lipid overload of the arterial wall and foam cell formation in response of endothelial activation and inflammation leading to plaque formation that can evolves towards plaque rupture and thrombosis.
Carotid-femoral pulse wave velocity (PWV) is the gold standard for clinical assessment of arterial stiffness. PWV is an independent cardiovascular risk factor and predictor of future cardiovascular events. 1 PWV increases two-fold between age <30 years (6 m/s) and > _ 70 years (11 m/s) ( Figure 1 ) and is higher in men. 2 The increase in PWV with aging is shared by most mammals with the exception of the longest living rodent, the naked mole rat (NMR), a species that does not seem to undergo ageassociated arterial stiffening. 3 Systolic blood pressure and pulse pressure (PP) increase from central to peripheral arteries ( Figure 1) . The ratio between brachial PP and central PP (defined as PP amplification) decreases with aging and arterial stiffening since the increase of PP with age is more pronounced in central than in peripheral arteries. The impact of the attenuation of PP amplification on cardiovascular mortality is threefold higher in women than in men over 55 years of age. 4 Increasing experimental data indicate a pivotal contribution of vascular smooth muscle cell (VSMC) plasticity in aging 5, 6 inducing vascular remodelling. The processes that lead to age-related VSMC structural changes include chronic inflammation, mechano-stimuli, cell death, calcification, and epigenetic events; these factors promote disturbances in VSMC function to maintain contraction and synthesis and assembly of extracellular matrix (ECM) proteins, 7 all of which undergo deterioration with age.
VSMCs in large arteries synthetize and secrete ECM proteins that contribute to arterial elasticity ( Figure 1) . Cell-ECM interactions via proteoglycans (PGs) are of particular importance in large artery function in determining vascular compliance. 8 VSMCs of small muscular arteries and arterioles are responsible for vasomotor tone and myogenic response that control arterial diameter. Vascular remodelling under the control of VSMCs that changes their phenotypes in response to pressuredependent stress of the arterial wall is mainly the characteristic of large arteries and small arteries and does not affect the arterioles. 9 The paradigm of age-related arterial stiffness has recently shifted from elastin/collagen content to cell-ECM interactions and VSMC tone as key molecular/cellular determinants of arterial wall stiffness. In addition, it has been extended from aortic stiffness to include the concept of VSMC stiffness 10 depending mainly on the architecture of cytoskeletal proteins and focal contacts. The influence of central pressure and tensile pulsatile circumferential stress must be thus expanded to the mechanobiology of individual cells and integrated in complex networks. These networks incorporate the coupling between vascular inflammation, progenitor cells, and vascular remodelling. We will further investigate VSMC plasticity and the importance of transcription factors, in particular serum response factor (SRF) in atherosclerotic lesions and arteriosclerosis. Age-related regulation of VSMCs will be described through the role of selected molecules located in the ECM (PGs, cytokines, transglutaminases), within the membrane [integrins, G-protein-coupled receptors (GPCRs), glycosphingolipids], or inside the cells (intermediate filaments, nicotinamide phosphoribosyltransferase). Endothelial cells (ECs), VSMCs, and fibroblasts contribute either directly or indirectly to mechanical homeostasis in the vascular wall. Loss of mechanical homeostasis with aging triggers interactions of these cells with platelets, immune cells, and stem cells. These interactions are associated with inflammatory and immune responses that cause the long-term vascular remodelling. We will summarize recent findings on inflammation and its resolution. Stiffness of VSMCs which has emerged as a new determinant of arterial stiffness will be discussed in term of its contribution to the increase in wall rigidity with aging. Finally, we will conclude on the central role played by VSMCs in the field of integrative biology.
Slowing of VSMC aging and selective molecules that regulate this process are emerging as exciting possibilities for controlling vascular disease. This review aims to delineate the mechanisms by which intramural cells sense and regulate the interaction of the cell with the ECM that Figure 1 Schematic diagram illustrating the pulsatile nature and the structure of the circulatory system and age-related changes in VSMC stiffness and arterial stiffness. Blood pressure propagates along the arterial tree at a given velocity (PWV). In young individuals, systolic and PPs are higher in peripheral than in central arteries and aortic PWV is lower than peripheral PWV (stiffness gradient). During aging, the increase in central systolic pressure (red dot pressure trace in aorta) induces the progressive loss of this PP amplification and inversion of the stiffness gradient. At the structural level, the VSMC/ECM ratio, the size of FAs and VSMC stiffness are higher in small arteries than in aorta. With aging, VSMC stiffness increases to the same extent in abdominal and thoracic aorta.
endows arteries with much of their mechanical functionality and structural integrity, 11 and the complex interactions amongst differently sized vessels.
VSMC signature
Expression of selective or specific contractile proteins characterizes the differentiation state of VSMCs. An early marker is a-smooth muscle actin (a-SMA), whereas caldesmon, calponin, and SM22a are expressed at the mid-stage of differentiation. Mature, fully differentiated VSMCs express high levels of SM-myosin heavy chain (SM-MHC) and exhibit a low proliferative index. 6 These proteins are differentially expressed along the arterial tree. Proteomic analyses of VSMCs identified as much as 232 among 1628 proteins exclusively present in aorta VSMCs and 168 proteins exclusively present in femoral VSMCs. 12 A network analysis identified signalling pathways and regulatory processes that contributed to differentiate VSMCs in link with their location. 13 Accumulating evidence suggests that humoral factors, mechanical forces, cell-cell, and cell-matrix interactions, various inflammatory mediators, and transcriptional regulatory pathways that control the gene expression program of VSMCs are key mediators governing VSMC differentiation and phenotypic switching. 6 
VSMC plasticity
The environmental changes caused by aging drive a switch from a quiescent contractile phenotype (differentiated VSMCs) to a synthetic phenotype (dedifferentiated VSMCs) characterized by reduced expression of SMC-specific contractile proteins (a-SMA, SM-MHC, and calponin) as well as increased cell proliferation and production of pro-inflammatory cytokines. Remarkably, these two phenotypes share considerable overlap and VSMCs display a wide range of intermediate phenotypic states. 5 Aging males are more prone than females to VSMC changes towards a synthetic phenotype. 14 
Regulation of VSMC phenotypic plasticity by growth factors
Platelet-derived growth factor (PDGF) and transforming growth factor (TGF-b) are master regulators of VSMC phenotypic plasticity. 5 PDGF-BB and PDGF-DD promote down-regulation of VSMC-specific contractile genes by activation of their receptor PDGFR-b. Canonically, the action of PDGF-BB depends on the transcription factors Krüppel-like Factor 4 (KLF4) and ETS-like transcription factor-1 (Elk-1), and functions by disrupting the binding of myocardin to SRF (Figure 2) . 17 Translocation of SRF out of the nucleus through a PDGF-stimulated PI3K-dependent Akt signalling pathway and activation of a Ras-dependent pathway also repress VSMC-specific contractile marker genes. Alternatively, PDGF-BB has been reported to degrade contractile proteins by activation of autophagy ( Figure 2 ) which also elicits cytoprotective effects through removal of proteins damaged by age-associated increase in oxidative stress. 18 Emerging evidence also proposes that PDGF triggers osteogenic switching that occurs during aging, through activation of mitogenactivated protein kinases (MAPKs), small mothers against decapentaplegic (Smad) 1/5/8, and protein kinase C (PKC) signalling upon binding to its receptor (Figure 2) . 19 The diversity of VSMC phenotypic modulation in aging is hallmarked by the inflammatory state of VSMCs within atherosclerotic plaques. Although both interleukin (IL)-1b and PDGF-DD repress SMC differentiation marker genes and up-regulate pro-inflammatory genes, the transcription factor nuclear factor jB (NF-jB) is a critical mediator of the effects of IL-1b but is not involved in the PDGF-DDinduced phenotypic modulation. 20 PDGF-DD primarily induces downregulation of the pro-inflammatory cytokine CCL20 and up-regulation of RGS17 involved in cell proliferation and migration ( Table 1) .
20
Cell migration requires an activation of mitochondrial energetic function, in particular by the dynamin-like protein 1 (DLP1) which regulates the step of mitochondrial fission ( Figure 2) . A reduction of mitochondrial fission using the dominant-negative mutant DLP1-K38A or DLP1 siRNA prevents the PDGF-induced VSMC migration through a decrease in respiration coupling efficiency and thus in ROS production through increased inner membrane potential. In vivo expression of DLP1-K38A in mice decreases intimal thickening after arterial wire injury. 21 In contrast to PDGF, the TGF-b, whose maturation and secretion are modulated by elastin microfibril interface-located protein 1 (EMILIN1), 22 promotes the contractile phenotype. TGF-b works through phosphorylation of Smad2/3 and Smad1/5/8 downstream of the signalling type I receptor kinase ALK5. 23 This increases phosphoSmad2/3 binding to a-SMA, calponin and SM22a promoters ( Figure 2) . The opposite effects of PDGF and TGF-b on VSMC phenotype switching are tightly regulated by microRNAs, in particular miR143/145, miR221 and miR222, and miR21 and miR24. 24 In the context of intimal hyperplasia, elevated TGFb/Smad3 up-regulates canonical Wnt/b-catenin signalling thereby promoting VSMC proliferation. 25 
Regulation of VSMC differentiation by specific transcriptional machinery
VSMC plasticity is regulated by complex transcriptional pathways and depends on combinatorial interactions of cis-acting elements and transacting factors. 6 The SRF/myocardin-dependent versatile control of SMC phenotype illustrates this general concept and has extensively been reviewed previously. 17, 26 Binding of the trans-acting factor SRF, a mcmagamous-deficiens-srf box-containing DNA protein, to a DNA sequence [a CC(AT) 6 GG motif] called the CArG box (cis-acting element) induces transcription of SMC marker genes to activate the differentiation program. Interaction of SRF with SMC specific/selective coactivators belonging to the myocardin family of transcriptional coactivators, including myocardin and myocardin-related transcription factors A and B (MRTF A/B), strongly enhances its affinity for the CArG elements of VSMCspecific contractile genes ( Figure 2) . In contrast, interaction with members of the ternary complex factor family of ETS domain protein such as Elk-1 promotes the expression of immediate-early genes (e.g. c-fos) and VSMC dedifferentiation. 27 Complex formations between SRF and these . 27 KLF4 has also been identified as a potent repressor of contractile genes through cooperation with phosphorylated Elk-1, modifications of chromatin structure of CArG box-containing promoters, sequestration of SRF, and reduction of myocardin expression. 20 Downregulation of Elk-1 and KLF4 by miR143/145, targeting of myocardin transcripts by miR221/222 and epigenetic modifications such as acetylation of histones 3 and 4 and dimethylation of lysines 4 and 79 on histone 3 also play a major role in VSMC phenotypic plasticity. 20 In addition to its canonical cytoplasmic Akt antagonizing function, PTEN, a dual specificity protein tyrosine phosphatase, selectively associates in the nucleus with the N terminus domain of SRF to form a multi-protein complex with myocardin on promoter elements of VSMC contractile genes, which, in turn, maintains the differentiated VSMC phenotype. 28 Consistent with a key role of the nucleo-cytoplasmic trafficking of PTEN to dynamically induce VSMC phenotypic switching, a decreased expression of PTEN has been reported in atherosclerotic lesions from human patients. 28 Exaggerated production of ROS and the stress-induced premature senescence of the VSMC phenotype is a hallmark of vascular aging. The transcription factor, NF-erythroid-derived 2-related factor 2 (Nrf2) orchestrates the transcriptional response of cells to oxidative stress by driving the expression of antioxidant genes via its binding to antioxidant response elements in their promoters. Age-related down-regulation of vascular Nrf2 expression at the mRNA and protein level as well as dysfunction of the pathways governing the nucleo-cytoplasmic shuttling of Nrf2 sensitize VSMCs to oxidative stress-induced damage (Figure 2) . 29 The recent study showing that Exendin-4, a glucagon-like peptide-1 analogue, protects against Angiotensin II (Ang II)-induced VSMC premature senescence through acetylation of Nrf2 that facilitates its accumulation in the nucleus provides a regulatory mechanism for the maintenance of the redox homeostasis. 29 Nrf2 activation has also been identified as the antioxidant transcriptional pathway mediating the protective effect the anti-aging protein klotho. 30 Interestingly, levels of Kelch-like ECH-associated protein 1 (Keap1) and b-transducin repeat-containing protein (bTrCP) which promote Nrf2 proteasomal degradation are linked to rodent maximal lifespan potential and thus are significantly reduced in the NMR. 31 
Summary
Aging is associated with a shift towards VSMC dedifferentiation mainly orchestrated by PDGF and SRF/Elk-1 paralleled by a lower activity of the differentiation program triggered by SRF/myocardin and TGF-b. Decrease in Nrf2 with aging acts additionally by reducing the expression of antioxidant genes leading to loss of the plastic nature of VSMCs and senescence. 
Extracellular molecules
Elastic fibres, fibrillar collagens, and glycosaminoglycans (GAGs) are the most common structural constituents thought responsible for the passive mechanical properties of the ECM. 11 Classically, an increase in collagen and decrease in elastin have become conceptually dogmatic as crucial changes in ECM attributed to aging and contributing to stiffening of the elastic arteries ( Figure 2) . The different functions of the collagen isoforms are thought to explain gender-specific differences in agerelated arterial stiffness. A transcriptional profiling of monkey aortas identified $600 genes differentially expressed with aging with only 5% shared between males and females. 32 A larger number of genes participating in ECM composition were significantly regulated with aging in males, in particular type III collagen (an isoform with elastic characteristics) and type VIII (an isoform involved in VSMC migration) which are down-regulated and up-regulated, respectively, only in males. 32 However, controversial data have been reported on collagen expression during aging between species suggesting the role of other aortic wall components or mechanisms at the level of VSMCs in arterial stiffening. Aging also generates an imbalance between proteases such as matrix metalloproteinases (MMPs) and their inhibitors as well as chronically increased expression of low-grade circulating inflammatory cytokines and chemokines such as monocyte chemoattractant protein-1 (MCP-1). Activation of the renin-angiotensin-aldosterone system contributes to arterial inflammation, ECM deposition, elastin fracture and VSMC migration, proliferation or senescence, all involved in age-related arterial remodelling. 33 
Elastin and collagen
Cumulative data from the literature have reported a vascular aging continuum triggered by mechanical fracture of elastic lamellae that is amplified by calcification, glycation/carbamylation, and lipid peroxidation as previously reviewed. 34 The fragmentation of the elastin network with aging enhances its proteolysis by specific elastases, which, in turn generates elastin-derived peptides. These peptides stimulate SMC proliferation via interactions with the elastin receptor complex, a signalling transducer involving activation of G proteins followed by the opening of L-type calcium channels and a sequential activation of tyrosine kinases. These peptides also promote VSMC differentiation in osteoblast-like cells ( Table 1) .
In normal aging, the increase in collagen production together with the irreversible fragmentation of elastic fibres ( Figure 2 ) confer a shift of the mechanical load (circumferential wall stress) onto the stiffer collagen fibres. The stiffness of collagen can be increased through enzymatic cross-linking by lysyl oxidase (LOX) during fibre assembly and nonenzymatic advanced glycation end-products (AGE)-mediated crosslinking at sites of cleavage by collagenases thereby interfering with proteolytic degradation. 35 Consistent with a key role of LOX-induced cross-linking, Lox deletion in mice is accompanied with fragmented elastic fibres causing increased aortic stiffness under the physiological range of pressure compared with control mice. 36 Differential expression of the so-called matrisome including ECM core components, ECM-associated components, and VSMC cell cycle genes has been proposed to be modified in a vascular location specific manner to explain these findings. Decreased expression of LOX with aging ( Figure 2 ) leading to altered fibrillary collagen argues for a role of collagen disarray in addition to the elastin/collagen ratio in arterial stiffening with age as previously suggested 37 as well as other VSMC-dependent mechanisms.
Cytokines and metalloproteinases
Numerous studies of aging vessels have revealed the crucial role of proinflammatory cytokines in ECM changes. The triad of MCP-1 and its cognate receptor, chemokine (C-C motif) Receptor-2 (CCR2), MMP-2, and TGF-b1 forms a feed-forward signalling loop orchestrated by Ang II, which enhances collagen production and VSMC migration in age-related Table 1) . 33 Activation of CCR2 by MCP-1 has also been proposed to utilize G aq/11 -phospholipase Cb3-protein kinase Cddependent serine phosphorylation of cortactin, an actin nucleation-promoting factor, that, in turn, interacts with verprolin homologous protein 2 (WAVE2) to promote G-actin polymerization, F-actin stress fibre formation and VSMC migration ( Figure 2) . 38 More recently, myostatin, also known as growth differentiation factor 8 (GDF-8), that belongs to the TGF-b superfamily and whose expression in medial VSMCs is increased during early aortic wall remodelling, was shown to up-regulate the MCP-1/CCR2 axis via JNK activation and to enhance VSMC migratory rate, suggesting that myostatin may be associated with pro-inflammatory changes during arterial aging ( Table 1) . 39 Cardiotrophin-1 (CT-1), a cytokine of IL-6 superfamily is expressed by aortic VSMCs and its expression is increased in VSMCs from hypertensive rats. CT-1 stimulates in vitro the expression of collagen and fibronectin, enhances MMP activities, produces proliferation, apoptosis, and senescence of VSMCs, as well as increases the NF-jB signalling pathway activity. 40 Absence of CT-1 in mice confers reduced arterial stiffening with aging and increases life span. The protective mechanism involves decreased oxidative stress and pro-inflammatory state. 41 VSMC apoptosis causes release of IL-1a which induces IL-6 release by adjacent VSMCs, that in turn promotes migration, proliferation, and collagen synthesis. 42 Similar VSMC responses are driven by the increase in plasma palmitate level which up-regulates IL-8 expression through the TLR4/ NF-jB signalling pathways in vascular inflammation. 43 The Ang II signalling signature in aging arterial wall includes activation of MMP-2/-7/-9/-14 and increased expression of MCP-1, calpain-1, TGFb1, milk fat globule-epidermal growth factor 8 (MFG-E8), and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase as previously reviewed (Figure 2) . 33 The increase in MMP-2 and MMP-9 comes from both enhanced transcription/translation and an imbalance between activators such as membrane-Type 1 matrix metalloproteinase and plasminogen activator and inhibitors including tissue inhibitor of MMP-2 and plasminogen activator inhibitor. MMP-9 and MMP-13 are also increased in the aging arterial wall. Activation of MMP-1/-2/-9 has been reported to enhance the release of PDGF and MFG-E8 ( Figure 2) . Increased interaction between MFG-E8 and a v b 5 integrin in aging promotes VSMC invasion and proliferation. 44 Proteolysis of calponin-1 by activated MMP-2 contributes to the switching of VSMCs towards a dedifferentiated phenotype. 45 Cross-talk between calpain-1 and MMP-2 enhances collagen production and thereby triggers calcification with advancing age. 46 
Proteoglycans
The basement membrane (BM) of VSMCs and the fibrillar ECM are linked by PGs that are composed of GAGs chains covalently linked to core proteins and determine its thickness. 47 Hyaluronan (which does not bind to a protein core), the large chondroitin/dermatan sulfate GAGs versican, the small leucine-rich PGs (SLRPs) biglycan and decorin are synthetized by VSMCs. TGF-b and Ang II are essential determinants of GAG/PG production ( Figure 2) . PGs contribute largely to the viscoelastic properties of the vascular wall due to their biophysical properties, and its degree of hydration under the control of cyclic mechanical stresses and shear rates. Specific binding of PGs to several ECM proteins, growth factors, proteases and anti-proteases (thrombin, anti-thrombin, PAI-1, elastase), and cell adhesion molecules (selectins, PECAM) contributes to regulate cell proliferation, cell-matrix interactions, collagen matrix assembly, and sequestration of diffusible molecules (growth factors) within the vascular wall. Contrasting to their relative low content in the tunica media of the aorta and smaller arteries, there is a diffuse GAG accumulation in the media in hypertension, aging, and atherosclerosis. 8 Hyaluronan and versican are primordial in controlling the distribution of wall stress within the elastic lamellae via elastin-associated fibrillin-1. Mouse models of mutations in the MYH11 gene causing thoracic aortic aneurysm display loss of elastic fibres and focal accumulation of GAGs/PGs responsible for an increased arterial stiffness in the context of hypertension. 48 The increase in hyaluronan synthesis in aged human VSMC cultures promotes cell migration via extracellular signal-regulated kinase (ERK)1/2 phosphorylation, 49 consistent with its role in intimal thickening of small arteries in aging. Early changes in PG production by VSMCs from resistance arteries also precede the onset of hypertension in spontaneously hypertensive rats (SHRs), independently of cell proliferation. 50 VSMC polyploidy in aged rats produced a proportional decrease in the expression of decorin that can thus serve as a biomarker of aging. 51 In a mice model of Hutchinson-Gilford progeria syndrome, a clear accumulation of hyaluronan and collagen replaced the loss of medial VSMCs in the aorta. 52 The ability of heparan sulfate PGs produced by ECs to bind growth factors and chemokines in the media depends on the N-deacetylase-N-sulfotransferase1 of VSMCs. Its specific deletion in mice increased aortic stiffness without changes in collagen and elastin contents, together with a reduction of cell proliferation. 53 Besides the role of large type GAGs, proteome analyses have demonstrated that a down-regulation of SLRPs is associated with increased arterial stiffness. 54 Altogether, the structural and cellular effects of PGs explain that PG engineering may present a promising medical strategy for repair of damaged vascular tissue. 55 
Transglutaminases
Transglutaminases (TGases) are enzymes that catalyse a transamidation reaction leading to the cross-linking of proteins though the formation of N-e-(c-glutamyl)lysine isopeptide bonds. 56 There are nine proteins in the TGase gene superfamily, at least three of which are expressed in vascular systems. TG2 in particular, is ubiquitously expressed in the vasculature, including in ECs, SMCs, fibroblasts, and monocytes-macrophages. TG2 is confined mainly to the cytosol, and a portion is secreted out of the cell and deposited in the ECM. 56 This process has been shown to be dependent on the activation of the enzyme. The secreted TG2 catalyses cross-linking of ECM proteins including fibronectin, fibrinogen, and laminin complexes. There is an emerging and important role of TG2 in regulating endothelial barrier function, small artery remodelling, and atherosclerosis. 57 TG2 also mediates vascular calcifications through accumulation and nuclear localization of b-catenin in VSMCs. 56 Crosslinking activity of TG2 has been shown to be inhibited in vitro by nitric oxide (NO) through protein S-nitrosylation of key cysteine residues including the active C277. 56 Decreased NO bioavailablility and increased arterial stiffness are the hallmarks of altered cardiovascular function such as occurs with age. 58 Increased arterial stiffness can be considered to be associated with decreased TG2 S-nitrosylation. Furthermore, because the active C277 is important in the export of TG2 to the cell surface/ECM, decreased Snitrosylation of this active site in the stiffened aorta increases TG2 export to the ECM. 59 That is, this increased export in aging contributes to increased vascular stiffness and dysfunction. TG2 S-nitrosylation is decreased and activity is increased in aging rat aorta, despite unchanged TG2 abundance. Moreover, in vivo inhibition of TG2 in old rats reduces vascular stiffness as measured by PWV. 60 The increase of ECM stiffness through the formation of collagen cross-linking by TG2 is associated Vascular smooth muscle cell in aging with the increase in contractile and proliferative response of the VSMC. 56 Recent studies have also shown the association of TG2 and vascular stiffness through cross-linking independent pathways. 61 TG2 activates NF-jB subsequent to active TGF-b, which in turn contributes to matrix synthesis ( Figure 2) . Another pathway involves GTPase function of TG2 resulting in decreased VSMC tone through activation of the BK-channel.
Summary
Besides the classical imbalance between elastin and collagen, the agerelated increase in ECM stiffness is triggered at the structural level by matrix degradation through MMPs and cytokines, sequestration of growth factors and proteases via accumulation of PGs and excessive cross-links by transglutaminases.
Membrane and intracellular pathways
A number of key signalling pathways, including integrin-related, GPCR signalling, actomyosin filaments, glycosphingolipids, and nicotinamide phosphoribosyltransferase are highly relevant to mechanotransduction and plasticity of VSMCs ( Table 1) .
Integrin receptors-FAs
Together with the adhesive properties of VSMCs, cell-matrix interactions represent important mechanisms of vascular stiffness and are controlled by mechanotransduction and mechanosensing. Integrins are involved in focal adhesion (FA)-stress fibre complex. At FAs, the binding of talin to vinculin reinforces the actin-talin linkage and drives cell spreading and directional migration. The accumulation of these proteins may recruit clusters of integrins leading to an enlargement of FAs. The combination of stress fibre activation and connected FAs represents one major mechanism by which cells respond to mechanical forces. Domain organization of talin includes a head domain that directly binds b integrins via actin-binding sites (ABS1-3) and a rod domain that binds F-actin either through ABS or vinculin-binding sites. 62 Srcmediated phosphorylation in FAs regulates conformational switch of vinculin from a closed conformation with auto-inhibited intramolecular interactions between the N-terminal head and the actin-binding tail domains to an open conformation binding F-actin. 63 On a soft substrate, interactions between integrin, talin, and actin exhibit a slip bond behaviour (high exchanges rates) that does not require vinculin and whose lifetimes are shortened as tension increases. Under mechanical tension (rigid ECM), high on rate and/or low off rate drive the reinforcement of vinculin-dependent linkage of talin to F-actin that activates catch bonds ( Figure 2) . The lifetime of the vinculin-actin bond depends on the directional interaction between the two molecules and was 10-times longer under pointed (-) end-directed load as opposed to the barbed (þ) end of the actin filament. 64 Dynamic associations between ECM, integrins, talin, vinculin, and the actomyosin cytoskeleton that generate forces, referred to as the molecular clutch, are responsible for FA force transmission and mechanosensitivity. 11 In addition, using fluorescent resonance energy transfer, it was shown that spatial variations in talin tension explain that peripheral (near cell edges) FAs exert higher levels of adhesion than central (near the nucleus) FAs. In addition to mechanical forces, lysophosphatidic acid (LPA) has been shown to modulate FA complexes. LPA-induced increased integrin adhesion to the ECM is dependent on ROS production (Figure 2 ), which increases with aging. 65 
G-proteins and GPCRs
The role of GPCRs is crucial in the development of endothelial and VSMC dysfunction in arterial stiffness. Activation of Ang II receptor, specifically type 1(AT1) receptors, represents a conserved GPCR signalling pathway in ECs and VSMCs. Cross-talks between AT1 and mineralocorticoid receptor (MR) (Figure 2 ) or AT1 and estrogen receptors are major determinants of arterial stiffening, cardiovascular remodelling and insulin resistance in aging. 66 Insulin and insulin-like growth factor I phosphorylate the scaffold protein insulin receptor substrate I (IRS-1) through insulin receptors, resulting in activation of PI3K and MAPK pathways. Ang II and aldosterone-mediated signalling stimulate mechanistic target of rapamycin (mTOR)/S6K1-dependent inhibition of IRS-1 phosphorylation, thus reducing insulin-induced vasodilation. The G-protein-coupled estrogen receptor (GPR30) attenuates Ang II-mediated VSMC proliferation by down-regulating AT1 expression.
In the vascular wall, G proteins regulate a wide range of cellular physiologic and pathologic processes including VSMC contractility, vasculogenesis, angiogenesis, blood pressure regulation, vascular permeability, and vascular remodelling during atherosclerosis and arteriosclerosis. Activation of GPCRs and subsequent signalling via G aq/11 are responsible for the phosphorylation of myosin light chain (MLC) by MLC kinase that triggers VSMC contraction whereas signalling via G a12/13 inhibits dephosphorylation of MLC by phosphorylation of MLC phosphatase. The regulation of VSMC contractility by GPCR signalling is markedly altered during aging (Figure 2) . It has been demonstrated that increased Rho kinase activity with age is associated with higher PWV values. 67 In addition, treatment with Fasudil, a Rho kinase inhibitor, increases vasodilation and lowers blood pressure. These two large G proteins also control VSMC plasticity independently of their downstream signalling on contraction and vascular tone. Inhibition of the large protein G a12/13 in apolipoprotein E deficient mice promotes atherosclerosis with a reduced expression of SM differentiation markers. In contrast, inhibition of G aq/11 decreases atherosclerosis with a re-expression of differentiation markers. 68 Thus, these two G proteins antagonistically regulate VSMC phenotypic switching in a context of vascular remodelling. Further studies are required to validate this concept in arteriosclerosis during aging. Downstream to these G proteins, several RhoA effectors may trigger vascular damage related to complex regulations. Among them, the GPCR Kinase 2 (GRK2) inhibits Ang II-induced VSMC proliferation and migration via TGF-b signalling 69 whereas GRK2 acts as a RhoA-activated ERK scaffold to promote epidermal growth factorinduced proliferation. Recently, it has been shown that increased RhoA activity and RhoA/Rho kinase signalling associated with VSMC-selective mutation of Cullin-3 (critical subunit of the CUL3-Ring-Ligase complex) enhance response to GPCR agonists leading to arterial stiffening and hypertension development. 70 
Actin-myosin and associated intermediate filaments
The actin and intermediate filament cytoskeleton proteins modulate force transmission between adhesion complexes at the cell surface and the nucleus. 71 The relationship between a reduction of actomyosin content and contractility appears very complex and the excitation/contraction coupling is not only dependent of the degree of differentiation but also on the general molecular environment of SMCs. Recently, it has been reported in cancer cells and fibroblasts that vimentin depletion induced phosphorylation of the microtubule-associated guanine nucleotide exchange factor GEF-H1, and thereby increased RhoA activity, MLC phosphorylation, actin stress fibre assembly, and cellular contractility. 72 . However, expression of vimentin and tubulin is not modified in VSMCs from aged monkeys despite increased cell stiffness. This suggests that changes in actin polymerization/depolymerization connected to FAs are the master inducers of VSMC stiffness in aging ( Figure 2) . 73, 74 Consistent with this, mice lacking vimentin exhibit increased expression of FAassociated proteins in the carotid artery. 75 Together with an increase in the expression components of BM and impaired endotheliumdependent relaxation, 76 these changes in FAs lead to increased arterial stiffness, demonstrating a co-ordinate role of intermediate filaments located in ECs and VSMCs. Regarding a more specific intermediate filament protein, the knock-out of desmin drives deficient VSMC-ECM interactions related to VSMC dedifferentiation resulting in increased arterial stiffness and mechanical strength of the vascular wall. 77 The actin cross-linking protein filamin A also plays an important role in small artery myogenic tone by negatively regulating the opening of the stretch-activated cationic channel Piezo1. In large arteries, cleavage of filamin A by calpain stimulates the RhoA/Rho kinase pathways resulting in an excessive vasoconstriction as occurs in hypertension and aging. 78 The cytoskeleton organization is also regulated by the nuclear lamina. Prelamin A accumulation induces VSMC aging by disruption of the lamin A/C with the linker of the nucleo-skeleton and cytoskeleton complex. This modification promotes FA reorganization to the cell periphery and attenuates activity of the small GTPase Rac1 responsible for migrational persistence of presenescent VSMCs. 79 Mutations in the LMNA gene or persistent accumulation of farnesylated prelamin A promote down-regulation of the metalloprotease ZMPSTE24 leading to oxidative stress, inflammation, senescence, and calcification of VSMCs. 80 Mutations of lamin A underlying
Hutchinson-Gilford progeria syndrome or atypical Werner syndrome translate into VSMC growth arrest and accelerated vascular aging. 81 
Glycosphingolipids
There is an established relation between sphingolipids and atherosclerosis with associated VSMC proliferation. 82 Sphingosine kinase, the enzyme responsible for sphingosine-1-phosphate synthesis has been shown to be associated with sphingolipid-dependent NO production following stimulation of the muscarinic receptors on ECs. 83 This suggests that processes that disturb the regulation of sphingolipid metabolism in the wall of blood vessels can have an intrinsic role on any downstream effect of disturbed endothelial function related to NO-dependent pathways. Bioavailability of NO is a signal that can lead to artery wall modification. This has been shown for protein post-translational modification leading to changes in the ECM due to increased cross-linking of collagen associated with S-nitrosylation effects on TG2 or other similar NO-dependent effects. 60 Hence, the earlier signalling cascade suggests that the sphingolipid biosynthesis pathway could be a target for prevention not only for atherosclerosis but also for arterial stiffness.
The sphingolipid ceramide has also been shown to be involved in cell signalling 82 causing vasodilation and mimics mechanotransduction in the vascular endothelium in terms of mechano-induced tyrosine phosphorylation of cell surface proteins. 84 Studies in age (and so arterial stiffness)-related reduction of endothelial-derived NO production showed elevated levels of ceramide due to chronic activation of neutral sphingomyelinases, without increase in ceramidase activity. Pre-treatment of aged rat vessel rings with the neutral sphingomyelinase inhibitor (GW4869) reversed the age-dependent loss of vasomotor function. 85 The glycosphingolipid signalling cascade has been described in ECs, monocytes, and VSMCs. 82 Recent studies in ApoE À/À mice fed a high fat diet have shown that inhibition of synthesis of the glycosphingolipids glugosylceramide and lactosylceramide can arrest the development of atherosclerosis, reduce VSMC proliferation and lower arterial stiffness independent of blood pressure. 86 
Nicotinamide phosphoribosyltransferase
The enzyme nicotinamide phosphoribosyltransferase (Nampt) is integral to VSMC metabolism 87 through association with NAD þ , an essential compound for generation of ATP. Decrease in Nampt content and activity ( Figure 2 ) has been shown to induce premature senescence in aging VSMCs, thus supporting a role for Nampt in slowing VSMC aging. Recent studies in human aortic tissue and Nampt-deficient mice have shown that reduction in Nampt-NAD þ activity was associated with aortic dilatation. 88 With increase in pressure and inflammation due to chronic infusion of Ang II, the aortas of the VSMC-Nampt deficient mice showed VSMC loss, decreased expression in a-SMA and type I collagen chains and intramural haemorrhage. This maladaptive response to Ang II is caused by premature VSMC senescence. A decline in genome integrity is a well-established hallmark of accelerated aging driving cellular senescence ( Figure 2) . The link between low Nampt and DNA damage including oxidized DNA, unresolved single-strand DNA breaks due to impaired PARP activity and predisposing to double-strand DNA damage argue for an Nampt-dependent NAD þ -PARP1-DNA repair axis in VSMCs. CpG hypermethylation of the NAMPT promoter was found to correlate with the silencing of NAMPT expression suggesting an epigenetic control of Nampt expression in dilated aortas. Conversely, aortic dilation may be responsible for repressed NAMPT promoter activity.
Summary
Arterial stiffening with aging likely involves GPCR signalling and actomyosin filaments. Although the involvement of FA dynamics and glycosphingolipids in vascular stiffness has been documented, an elucidation of the link with aging is still lacking. In contrast, the low expression of Nampt with age induces VSMC senescence but the functional consequence on arterial stiffness remains to be established.
Interactions with other cells
Intercellular communications between vascular cells (ECs, VSMCs, and fibroblasts) and platelets, immune cells, and stem cells, mainly through dynamic changes in their locations, contribute to the main events that play a key role in the development of arterial aging. Canonically, the media is a privileged site, avascular, and without leucocytes. Smooth muscle-to-macrophage transdifferentiation has emerged as an important new determinant of atherosclerosis. 5 During aging, activation of Ang II signalling, low-grade inflammation, and oxidative stress trigger an immune response contributing to the main events leading to hypertension and arteriosclerosis. 89 VSMCs express toll-like receptors involved in up-regulation of genes encoding components of the inflammasome associated with innate immunity. Involvement of adaptive immunity is established by the demonstration that the proinflammatory IL-6 cytokine produced by T cells, macrophages, and also VSMCs is involved in Ang II-induced phosphorylation of Janus kinase (JAK)2 and signal transducers and activators of transcription (STAT) 3. IL-17 produced by c/d T cells in synergy with TNF-a induces expression of VSMC pro-inflammatory genes. IL-18 receptor activation on VSMCs induces proliferation and migration independently of their pro-inflammatory effects. Recently, erythrocytes have been reported to be phagocytosed by VSMCs during the early stages of atheroma, thus enhancing the process of oxidation. 90 Vascular smooth muscle cell in aging Activation of the triggering receptor expressed on myeloid-1 cells (TREM-1) induces a non-resolving cardiovascular inflammation by means of an amplified immune response. Whereas TREM-1 present in both monocytes/macrophages, ECs, and VSMCs acts as the trigger of acute inflammation (Figure 3) , the transition into chronic inflammation hallmarking aging implicates also a failure in the resolution of inflammation. 91, 92 Although initially considered to be a passive process, it is now widely recognized that the resolution of inflammation indeed is an active process. Lipid mediators derived from the lipoxygenation of either arachidonic acid (i.e. lipoxins) or x-3 fatty acids (e.g. resolvins) oppose the actions of leucotrienes and act as the stop-signals needed for the resolution of inflammation and mediate, by means of specific receptors, a return to tissue homeostasis ( Figure 3) . 93 For example, enzymatic metabolism of x-3 essential polyunsaturated fatty acids yields a group of specialized pro-resolving mediators termed resolvins, which promote the resolution of acute inflammation. 94 Alterations of platelet-vessel wall interactions and vascular leucocyte infiltration in aging elicit an endothelial dysfunction characterized by loss of integrity and anticoagulant properties, which in turn contributes to local thrombin generation (Figure 3) . This thrombin exerts a v b 3 integrindependent proliferative and migratory effects on VSMCs via activation of FAs. 95 Infiltrating monocytes exhibiting pro-inflammatory phenotype are also able to be involved in Ang II-induced oxidative stress in ECs and VSMCs ( Figure 3) . 96 Extracellular vesicles derived from macrophage foam cells transport a 5 and b 1 integrins to the surface of VSMCs which activates the ERK and Akt pathways. 97 Another example of heterotypic cellular communications is the contact-dependent Notch signalling ( Figure 3) . ECs promote the expression of the Notch3 receptor on VSMCs, which down-regulates apolipoprotein D, a glycoprotein known to exert a role in aging and stress resistance and that attenuates the formation and stabilization of FAs involving collagen-binding integrins ( Table 1) . 98 Collectively, these findings outline an important role of Figure 3) . SirT1 promotes endothelial-dependent vasodilation by deacetylation of endothelial NO synthase (eNOS) and suppresses NF-jB and AT1-mediated pro-inflammatory signalling through multiple downstream molecular targets including MMPs, 99 thereby maintaining vascular homeostasis. 100 The decline in SirT1 levels in aging drives increased oxidative stress and inflammation as well as premature EC and VSMC senescence contributing to the onset of endothelial dysfunction and arterial stiffening. 101, 102 SirT1 synergizes with different molecule to exert its effects as recently demonstrated with the SM22a-casein kinase II-SirT1 complex forming a positive feedback loop to limit the anti-inflammatory response in VSMCs. 103 An increasing number of studies have pointed out the involvement of SirT1 in both pro-and anti-inflammatory pathways, suggesting that the development of sirtuin-activating compounds in aging should benefit from an integrated view of heterotypic interactions of vascular cells.
A recent observation has demonstrated that VSMCs are able to migrate into the adventitia to express progenitor cell markers. 104 This VSMC reprogramming regulated by the pluripotency-associated transcription factor KLF4 may initiate inflammation by differentiating into macrophages or participate to adaptive mechanisms in aged vessels by adopting a VSMC or EC phenotype. Indeed, the introduction of four induced pluripotent stem cell (iPSC) generating transcription factors (KLF4, OCT4, SOX2, and c-MYC) enabled VSMCs to revert to a partially reprogrammed phenotype, allowing further commitment towards functional ECs in a process involving members of the Notch pathway (Hairy enhancer-of-split 5 and Jagged-1). 105 Conversely, adventitial fibroblasts can be converted into activated myofibroblasts expressing markers of immature VSMCs. 106 These myofibroblasts that continually produce increased levels of type I collagen are abundant in fibrotic lesions and contribute to neointimal formation in aging together with dedifferentiated VSMCs. 107 
Summary
Altogether, many other cell types, including macrophages, could participate in inflammation and immune response to aging. Therefore, new modulators acting on these homotypic and/or heterotypic interactions such as integrin inhibitors, sirtuins, or pro-resolving lipid mediators could decrease age-induced vascular remodelling.
Emerging role of cellular stiffness
The regulation of arterial stiffness includes haemodynamics, ECM changes and stiffening of ECs and VSMCs. 10 Involvement of the dynamic actomyosin interactions including polymerization of G-actin to F-actin has been first identified as a mechanism in cell stiffness. 67, 108 The increase in cell stiffness depends of the degree of stretch of the preexisting F-actin and the recruitment of new F-actin. Single-cell micromechanical measurements by atomic force microscopy (AFM) provide information on cell topography and cell stiffness (local apparent Young's elastic modulus). In addition, cell adhesion to ECM is measured by the force required to disrupt the bonds between functionalized probes coated with fibronectin, vitronectin or collagens and cell surface. These measurements test the involvement of clustering of a 5 and b 3 integrins and the actin cytoskeleton as a determinant of whole tissue elasticity. 109 Increased endothelial contractility, the major determinant of EC stiffness, contributes to increased permeability, inflammation, and leucocyte transendothelial migration. 67 Endothelial MR contributes to vascular stiffness (assessed by PWV) and the stiff EC syndrome (assessed by AFM) associated with Western diet in mice. The mechanism involves increased endothelial sodium channel activation, insulin resistance, endothelial dysfunction, eNOS inactivity, induction of inflammation and oxidative stress and aortic fibrosis. 110 The decrease in NO bioavailability induces VSMC contraction and vascular stiffness. Vasoactive agents such as Ang II, adenosine or NO induce ECM adhesion, and cell stiffness changes in tandem with their effect on VSMC contractile properties. 111 These adhesive properties depend on integrin activation. VSMC stiffness depends on altered cytoskeletal polymerization/depolymerization and increased adhesive properties (Figure 2) . Recent studies, using a magnetic tweezer coupled with an RGD peptide, have established the correlation between the size of FAs, activation of FA kinase (FAK)-Src signalling complex, and VSMC stiffness for a given arterial site. 112 Inhibition of Src or FAK and thereby inhibition of FA dynamics also decreases aortic stiffening, suggesting a major role of FAs in agerelated VSMC changes and arterial stiffness. Consistent with a role of FAs in VSMC stiffness, when compared with elastic arteries, muscular arteries display increased size of FAs that paralleled with increased VSMC stiffness (Figure 1 ).
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Cellular stiffness is a response to changes in the biochemical properties of the ECM. Local fragmentation of elastic fibres, increase in collagen and cross-linking enzymes and calcification during aging drive increase in ECM stiffness, which in turn promotes cellular stiffness (Figure 2) . Activation of FAs is also proportional to the stiffness of ECM substrates.
Aging is a key contributor of increased arterial stiffness. This concept has been highlighted at the level of VSMC stiffness assessed by AFM in aged monkeys. 74 In aging, aortic stiffening is predominant in the abdominal compared with the thoracic aorta. The mechanism involves mainly disarray of both collagen and elastin without regional differences in VSMC stiffness (Figure 1) . 37 Intrinsic VSMC stiffness is attracting increasing attention in relation to mechanisms of age-and hypertension-related arterial stiffness. 10 In SHR, the causal contribution of cell stiffness to vascular stiffness has been suggested by the demonstration of a parallel increased stiffness at the tissue and single cell levels. 113 In hypertensive aging, cell stiffness and adhesion are higher than in the presence of aging or hypertension alone and occur independently of the content of elastin and collagen. 114 Recently, it has been demonstrated that increased VSMC stiffness is restricted to large elastic arteries but not small muscular arteries in hypertension. 115 The underlying mechanisms involve an increase in SRF/myocardin expression as well as their downstream targets caldesmon, calponin, and RhoA in thoracic aorta from SHR compared with arteries from Wistar-Kyoto rats before the onset of hypertension. Inhibition of SRF/myocardin axis in SHR reduced aortic stiffness in parallel with decreased cell stiffness.
Summary
Understanding the mechanisms of cellular stiffness is important to appreciate their contribution to mechanical properties at the tissue-level. Our knowledge would rapidly accrue with current molecular studies on the ECM-integrin-cytoskeletal axis and the myocardin/SRF complex in elastic and muscular arteries. A second major issue to be addressed is to elucidate whether these processes occur specifically in hypertension and aging-associated vascular damage.
Vascular smooth muscle cell in aging
Mechanobiology
The pulsatile nature of the intact circulatory system, and the fact the arteries are constantly in a state of tension, predisposes cells in the arterial wall (ECs and VSMCs) to undergo continuous oscillatory stress ( Figure 1) . Large arteries are distensible and dampen the blood pressure oscillations due to intermittent ventricular ejection. This process transforms the pulsatile flow into a constant flow in the microcirculation to provide sufficient oxygen delivery in different organs. In young individuals, reflected pressure waves limit the transmission of pulsatile pressure to the periphery and maintain PP amplification (Figure 1) . The cell membrane properties determine the strain due to the imposed stress which potentiates a cascade of cell-signalling pathways. The interaction between cells and ECM is central to the relatively new discipline of mechanobiology, which is enhanced by numerous recent advances in the broad field of molecular biology, particularly genetics and proteomics. The cellular, molecular, and structural aspects have been covered in other sections of this review. The aging process, in addition to altering ECM properties resulting in altered vascular stiffness of conduit arteries also affects the cellular interconnections, thus altering both the passive and active process of modulation of wall properties. 116 The overall biomechanical response of the arterial wall to applied stress (blood pressure) is determined by the mechanical properties of individual components, having different contributions in muscular and elastic vessels. The structural and contractile properties of VSMCs have been shown to result in differential response (either increased or decreased wall stiffness) at different degree of strain with identical stimulation (potassium cyanide) applied to the VSMCs. This differential response is explained on the basis of the structural integration of VSMCs with the ECM components, principally connections with elastin and collagen fibres. 117 In response to mechanical load, release of TGF-b increases production of matrix and activates MMP promoters. 118 This cytokine also increases integrin clustering and actomyosin activity. Valuable information on the role of VSMCs in the in vivo response of large conduit arteries to changes in haemodynamic stimuli has been obtained by experiments measuring pulsatile components of pressure and diameter. These experiments demonstrate effects of VSMCs with change in volume loading and venous return independent of pressure and neurogenic influences through activation of baroreceptor pathways. 119 In the canine aorta, these effects have been shown to modulate characteristic impedance in the presence of a pressure-dependent effect on the vessel wall stiffness. 120 An important effect of the presence of VSMCs in the vessel wall and their integration with other load-bearing components is the contribution of the VSMCs to wall viscoelasticity. The effect of viscoelasticity is manifested as a phase delay between applied pressure and diameter change and so is associated with energy dissipation and damping. 121 An interesting interpretation of the role of VSMCs has been described in terms of 'smart sensors', where the smooth muscle contributes to regulation of wall energetics, with enhanced activity in hypertension, and so is considered as a 'protective' mechanism. 122 The pressure dependency of arterial stiffness is an inherent property of the mechanical design of arteries. This is expressed through a strong association between blood pressure and arterial PWV, a surrogate measure of arterial stiffness, and which also changes significantly with age. 123 Compared with changes in other ECM components with age in large arteries, the effects of VSMCs is negligible regarding the pressure dependency of PWV. However, PWV has also been shown to be dependent on heart rate. 124 This invokes the role of wall viscoelasticity due to the presence of VSMCs. 125 Mechanosensing and mechanotransduction are becoming important emerging concepts in vascular mechanobiology, with VSMCs becoming an integral part in elucidation of pathophysiological response mechanisms. The VSMC sensing pathways are also implicated in maintaining vessel integrity, contribution to structural homeostasis and to structural disturbances contributing to vessel aneurysms and dissections. 126, 127 
Translational aspects
Studies of age-related changes in arterial stiffness in large cohorts show that muscular arteries change much less than the aortic trunk with age. 123 In youth, aortic stiffness, as measured by PWV, is lower than in the limb muscular arteries. With the higher rate of increase, the aortic PWV surpasses limb PWV in the 6th decade, thus altering the stiffness gradient between the aorta and peripheral arteries (Figure 1) . This stiffness gradient has been shown to be related to cardiovascular risk in patients with kidney disease and undergoing dialysis. It is also considered to be a pressure-independent index of vascular aging. 128 The reduction or abolition of the stiffness gradient between central aorta and peripheral muscular arteries results in a more uniform stiffness through the vasculature, thus allowing the pulsations generated by the beating heart to travel further in the vascular beds of vital organs. This has been suggested as a mechanism for end-organ damage, in organs with large blood through-put such as brain and kidney. Evidence of the effect of altered pulsatility and stiffness gradient on brain structure and cardiovascular risk has been found in large cohorts. 129, 130 In humans, the respective role played by VSMCs in large arteries compared with small arteries cannot be easily studied since PWV does not provide a direct measurement of vascular tone. However, previous investigations using radial arterial pressure waves, have shown that indexes of large and small artery elasticity can be differentially correlated with cardiovascular risk factors in men and women and that low-grade inflammation is associated with large artery but not with small artery elasticity. 131 It is generally admitted that the level of small artery elasticity provides information on the site of pressure wave reflection that depends on vascular wall remodelling. To date, pharmacological approaches and transgenic animal models have yielded similar or contradictory information on VSMC behaviour with aging. 132 With the advent of research on the NMR exhibiting no arterial stiffening with age, 3 new mechanisms operating at the level of VSMCs will emerge. In a reverse transcription approach, functional VSMCs ranging from contractile to synthetic cells derived from human iPSCs of patients can be differentiated into embryonic lineage-specific SMC recapitulating the pathology. Such an approach has been recently used in Marfan syndrome where CRISPR-Cas9 FBN1 editing to correct the C1242Y mutation in patient iPSC-derived SMCs decreased the levels of phosphorylated TGF-b pathway effectors. 133 
Conclusion
This review describes a narrative of the VSMC which lends itself to an integrated approach to uncovering the underlying mechanisms involving VSMCs in the biological response of blood vessels. In aging, the disappearance of the normal gradient in stiffness together with low-grade inflammation increases mechanical load on the vessel wall resulting in changes in gene expression in ECs and VSMCs. These changes are responsible for increased VSMC contractility and ECM deposition establishing a feedback loop connecting cellular stiffness to vascular stiffness. A complete understanding of the contribution of VSMCs requires integrating the mechanical properties of small-size muscular arteries. This raises the question whether VSMC tone influences small and large artery stiffness. However, paradoxical results in cellular stiffness between elastic and muscular arteries in hypertension (i.e. increased stiffness only in large arteries) suggest that the relation between cellular stiffness and contractility is very complex, depending not only on the degree of differentiation but also on the general molecular environment of VSMCs.
In view of the multitude of roles of VSMCs and feedback controls, 9 only omic approaches and computational models may extrapolate the overall effects on the vascular wall in light of haemodynamics and complex interactions amongst differentially sized vessels. Finally, while VSMC markers are unmeasurable in plasma, human iPSCs as a source of wellcontrolled VSMCs or for creating models of mechanotransduction have therapeutic promise in the dynamics of vascular aging and diseases.
